Synthetic biology is changing the way we think about diagnosing and treating microbiome-based diseases. At CC Bio, we harness the power of synthetic biology to engineer and edit the microbiome with surgical precision. Our goal is to eliminate microbiome-based disease in a potent, specific and prophylactic fashion, harmonising the relationship between eukaryotic and microbial cells. By considering the lifestyle needs of our patients, and understanding each microbiome-based disease holistically, we are elevating this fundamental aspect of human health out of the antibiotic era, putting power back in the hands of the consumer.
| Website | http://www.ccbio.co.uk |
| Employees | 5 (4 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology, Diagnostic Equipment |
| Keywords | Synthetic Biology, Precision Medicine, Disease Treatment, Microbiome Therapeutics, Biotechnology, Drug Discovery, Genetic Engineering, Biomedical Research, Pharmaceutical Research, Microbial Diagnostics, Gut Microbiome, Personalized Medicine, Biomanufacturing, Genome Editing, Therapeutics, Life Sciences, Biotechnology Research |
Looking for a particular CC Bio employee's phone or email?
David Corcoran is the Co-Founder and COO of CC Bio.
4 people are employed at CC Bio.